News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on LBT Innovations.
RELATED STOCKHEAD STORIES
News
Closing Bell: ASX ends higher but iron’s ordinary problem isn’t going away
News
ASX Small Cap Lunch Wrap: Who’s breaking down global barriers with pictures of cats today?
News
Top 10 at 10: Liontown leaps on $550m loan, AI stock eyes commercialisation
News
ASX Small Caps and IPO Weekly Wrap: The week we learned what Woolies is really worth
News
Top 10 at 11: Half-year numbers speak for themselves as reporting season marches on
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Thursday and the ASX200 is flat and porous. I am unhappy… But at least Bega made a lot of cheese
News
ASX Small Caps Lunch Wrap: Benchmark looks bewildered after Nvidia riches; Local boy does good
Health & Biotech
ASX Health Stocks: Cogstate falls as pipeline contracts; LBT delivers product to Thermo Fisher
Health & Biotech
ASX Health Winners January: ‘Invest in business not science’, as SHG and PAA top winners list
Health & Biotech
ASX Health Winners December: Health stocks beat market, look ‘undervalued’ going into 2024
Health & Biotech
Check Up: The reason people quit weight-loss drugs
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
News
ASX Small Caps and IPO Weekly Wrap: A double-century double-header makes this week one to remember
Health & Biotech
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
Health & Biotech
ASX Health Stocks: LBT Innovations picked by AstraZeneca as partner, share price surges 22pc
News